Cargando…
Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial
BACKGROUND: In the majority of cases, trigeminal neuralgia (TN) is a unilateral condition with ultra-short stabbing pain located along one or more branches of the trigeminal nerve. Although prophylactic pharmacological treatment is first choise, considering of insufficient effect or unacceptable sid...
Autores principales: | Zhang, Haifeng, Lian, Yajun, Ma, Yunqing, Chen, Yuan, He, Caihong, Xie, Nanchang, Wu, Chuanjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194456/ https://www.ncbi.nlm.nih.gov/pubmed/25263254 http://dx.doi.org/10.1186/1129-2377-15-65 |
Ejemplares similares
-
Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study
por: Zhang, Haifeng, et al.
Publicado: (2017) -
Central antinociceptive activity of peripherally applied botulinum toxin type A in lab rat model of trigeminal neuralgia
por: Wu, Chuanjie, et al.
Publicado: (2016) -
Factors affecting the therapeutic effect of botulinum toxin A on trigeminal neuralgia: A follow-up retrospective study of 152 patients
por: Zhang, Haifeng, et al.
Publicado: (2019) -
Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect
por: Wu, Shouyi, et al.
Publicado: (2019) -
Therapeutic Efficacy of Botulinum Toxin in Trigeminal Neuralgia
por: Kayani, Abdul Mueez Alam, et al.
Publicado: (2022)